Figure 3From: A 64-week, multicenter, open-label study of aripiprazole effectiveness in the management of patients with schizophrenia or schizoaffective disorder in a general psychiatric outpatient settingResponse rate by study week. Response = CGI-I score of 1 (very much improved), 2 (much improved) and 3 (minimally improved). CGI-I = Clinical Global Impression scale Improvement score.Back to article page